Atlas Trials

A Bioequivalence Study of Capecitabine Tablets

Clinical trial NCT01846650 · COMPLETED

Trial details

NCT number
NCT01846650
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer or Metastatic Colorectal Cancer
Start date
2012-12-01
Primary completion
2013-06-01
Enrollment
36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.